[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Vella et al., 2012 - Google Patents

Identification of a novel amyloid precursor protein processing pathway that generates secreted N‐terminal fragments

Vella et al., 2012

View PDF @Full View
Document ID
6588718585143552508
Author
Vella L
Cappai R
Publication year
Publication venue
The FASEB Journal

External Links

Snippet

Alzheimer's disease (AD) is a neurodegenerative disorder of the central nervous system. The proteolytic processing of the amyloid precursor protein (APP) into the β‐amyloid (Aβ) peptide is a central event in AD. While the pathway that generates Aβ is well described …
Continue reading at faseb.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease

Similar Documents

Publication Publication Date Title
Vella et al. Identification of a novel amyloid precursor protein processing pathway that generates secreted N‐terminal fragments
Ludewig et al. Novel insights into the physiological function of the APP (gene) family and its proteolytic fragments in synaptic plasticity
Sikora et al. Cellular senescence in brain aging
Bright et al. Human secreted tau increases amyloid-beta production
Fanutza et al. APP and APLP2 interact with the synaptic release machinery and facilitate transmitter release at hippocampal synapses
Amadoro et al. Interaction between NH2-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration
Swanson et al. Extracellular tau oligomers induce invasion of endogenous tau into the somatodendritic compartment and axonal transport dysfunction
Schilling et al. APLP1 is a synaptic cell adhesion molecule, supporting maintenance of dendritic spines and basal synaptic transmission
Origlia et al. Aβ-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: The role of RAGE
Sotthibundhu et al. Aβ1–42 stimulates adult SVZ neurogenesis through the p75 neurotrophin receptor
Chaplot et al. Secreted chaperones in neurodegeneration
Armato et al. Alzheimer's disease: an update of the roles of receptors, astrocytes and primary cilia
US10138286B2 (en) Methods and compositions for inhibiting the effects of amyloid beta oligomers
Balducci et al. The γ-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice
Lee et al. A potential therapeutic effect of saikosaponin C as a novel dual‐target anti‐Alzheimer agent
Cho et al. TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-β
US20100081613A1 (en) Methods and compositions for enhancing memory
Lantz et al. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer’s disease pathology models
Afreen et al. The formation of small aggregates contributes to the neurotoxic effects of tau45-230
Demuth et al. Deletion of p75NTR rescues the synaptic but not the inflammatory status in the brain of a mouse model for Alzheimer’s disease
Gulisano A renewed vision for Amyloid beta and tau in Alzheimer s disease pathophysiology
Ferreira Rodrigues Propagation of Tau pathology in Alzheimer disease
Jang et al. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in Alzheimer’s disease
Mohammadi Investigation of the therapeutic potential of the neuroprotective prion protein N1-fragment in cellular and mouse models of Alzheimers and prion disease
Gühna et al. Rapid astroglial stress response and elevation of endogenous BiP levels promote neuronal survival in hippocampal slice cultures